Tranexamic Acid Reduces Mitochondrial DNA Release and Inflammation in Intestinal Cells Following OGD/R Injury

Researchers have identified that tranexamic acid reduces the release of mitochondrial DNA and limits inflammatory responses in intestinal epithelial cells following oxygen-glucose deprivation and reperfusion (OGD/R) injury. The study highlights a specific biological mechanism in which the medication interferes with the cellular processes that trigger inflammation after these types of injuries occur.

The investigation focused on how cells react to the stress of oxygen and glucose loss, a condition that often leads to the release of mitochondrial DNA into the extracellular space. By applying tranexamic acid to intestinal epithelial cells subjected to OGD/R, the research team observed a decrease in the signaling pathways that typically drive the inflammatory cascade. These findings provide data on the interaction between the drug and mitochondrial stability during cellular recovery. The study details the specific pathways involved in this process, offering a clearer picture of how tranexamic acid influences cellular behavior under conditions of metabolic stress.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 6, 2026

Author

GOAI